<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-G021ENYF</identifier><date>1999</date><creator>Čufer, Tanja</creator><relation>documents/doc/G/URN_NBN_SI_doc-G021ENYF_001.pdf</relation><relation>documents/doc/G/URN_NBN_SI_doc-G021ENYF_001.txt</relation><format format_type="issue">2</format><format format_type="volume">3</format><format format_type="type">article</format><format format_type="extent">str. 72-75</format><identifier identifier_type="COBISSID">10968281</identifier><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-G021ENYF</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">Clinical trials</subject><subject language_type_id="eng">Decision making</subject><subject language_type_id="eng">Evidence-based medicine</subject><subject language_type_id="eng">Neoplasms</subject><subject language_type_id="slv">novotvorbe</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="eng">Therapy</subject><subject language_type_id="eng">tumor</subject><subject language_type_id="slv">zdravljenje</subject><title>Bomo pri zdravljenju raka sledili dokazom (evidence-based medicine) ali ugledu (eminence-based medicine)?</title></Record>